High-risk HPV and survival in patients with oral and oropharyngeal squamous cell carcinoma - 5-year follow up of a population-based study.
Annertz, Karin LU ; Rosenquist, Kerstin ; Andersson, Gunilla ; Jacobsson, Helene ; Hansson, Bengt-Göran LU and Wennerberg, Johan LU
(2014)
In Acta Oto-Laryngologica
134(8).
p.843-851
- Abstract
- Abstract Conclusion: No statistically significant 5-year survival difference was seen in patients with oral and oropharyngeal squamous cell carcinoma (OOPSCC) between high-risk HPV-positive and -negative groups in this population-based study. Objectives: To see if the formerly observed higher risk for recurrence or second primary tumour (SPT) in high-risk HPV-positive patients with OOPSCC corresponds to worse survival. Methods: A total of 128 consecutive, previously untreated patients with OOPSCC, who were part of a population-based case-control study in southern Sweden during 2000-2004, were included. A mouthwash sample was collected and exfoliated cells were collected with cotton-tipped swabs from the tonsillar fossa and the tumour.... (More)
- Abstract Conclusion: No statistically significant 5-year survival difference was seen in patients with oral and oropharyngeal squamous cell carcinoma (OOPSCC) between high-risk HPV-positive and -negative groups in this population-based study. Objectives: To see if the formerly observed higher risk for recurrence or second primary tumour (SPT) in high-risk HPV-positive patients with OOPSCC corresponds to worse survival. Methods: A total of 128 consecutive, previously untreated patients with OOPSCC, who were part of a population-based case-control study in southern Sweden during 2000-2004, were included. A mouthwash sample was collected and exfoliated cells were collected with cotton-tipped swabs from the tonsillar fossa and the tumour. Specimens were analysed for HPV DNA using nested polymerase chain reaction (PCR). Disease-specific survival (DSS) and DSS difference between HPV-negative and HPV-positive patients were calculated. The relationship between age, stage, high-risk HPV status and DSS was assessed. Oral and oropharyngeal tumours were assessed separately. Results: Mean DSS in months was 80.7/68.6 (high-risk HPV-negative/high-risk HPV-positive) for oral cavity tumours (p = 0.18) and 67.6/78.3 (high-risk HPV-negative/high-risk HPV-positive) for oropharyngeal tumours (p = 0.47). For oral cavity tumours, age, T status, N status and stage all showed significant differences in DSS. For oropharyngeal tumours, no significant difference regarding DSS was found. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4528438
- author
- Annertz, Karin
LU
; Rosenquist, Kerstin
; Andersson, Gunilla
; Jacobsson, Helene
; Hansson, Bengt-Göran
LU
and Wennerberg, Johan
LU
- organization
- publishing date
- 2014
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Acta Oto-Laryngologica
- volume
- 134
- issue
- 8
- pages
- 843 - 851
- publisher
- Taylor & Francis
- external identifiers
-
- pmid:24930912
- wos:000340137200012
- scopus:84904369730
- ISSN
- 1651-2251
- DOI
- 10.3109/00016489.2014.890289
- language
- English
- LU publication?
- yes
- id
- f91397d5-ffd5-4c84-81a1-d8ceb37015f0 (old id 4528438)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/24930912?dopt=Abstract
- date added to LUP
- 2016-04-01 10:12:01
- date last changed
- 2022-02-17 07:42:37
@article{f91397d5-ffd5-4c84-81a1-d8ceb37015f0,
abstract = {{Abstract Conclusion: No statistically significant 5-year survival difference was seen in patients with oral and oropharyngeal squamous cell carcinoma (OOPSCC) between high-risk HPV-positive and -negative groups in this population-based study. Objectives: To see if the formerly observed higher risk for recurrence or second primary tumour (SPT) in high-risk HPV-positive patients with OOPSCC corresponds to worse survival. Methods: A total of 128 consecutive, previously untreated patients with OOPSCC, who were part of a population-based case-control study in southern Sweden during 2000-2004, were included. A mouthwash sample was collected and exfoliated cells were collected with cotton-tipped swabs from the tonsillar fossa and the tumour. Specimens were analysed for HPV DNA using nested polymerase chain reaction (PCR). Disease-specific survival (DSS) and DSS difference between HPV-negative and HPV-positive patients were calculated. The relationship between age, stage, high-risk HPV status and DSS was assessed. Oral and oropharyngeal tumours were assessed separately. Results: Mean DSS in months was 80.7/68.6 (high-risk HPV-negative/high-risk HPV-positive) for oral cavity tumours (p = 0.18) and 67.6/78.3 (high-risk HPV-negative/high-risk HPV-positive) for oropharyngeal tumours (p = 0.47). For oral cavity tumours, age, T status, N status and stage all showed significant differences in DSS. For oropharyngeal tumours, no significant difference regarding DSS was found.}},
author = {{Annertz, Karin and Rosenquist, Kerstin and Andersson, Gunilla and Jacobsson, Helene and Hansson, Bengt-Göran and Wennerberg, Johan}},
issn = {{1651-2251}},
language = {{eng}},
number = {{8}},
pages = {{843--851}},
publisher = {{Taylor & Francis}},
series = {{Acta Oto-Laryngologica}},
title = {{High-risk HPV and survival in patients with oral and oropharyngeal squamous cell carcinoma - 5-year follow up of a population-based study.}},
url = {{http://dx.doi.org/10.3109/00016489.2014.890289}},
doi = {{10.3109/00016489.2014.890289}},
volume = {{134}},
year = {{2014}},
}